Follow Us :

Digital Pathology Market by Product (Scanners, Software, Communication Systems, Storage Systems), by Type (Human Pathology, Veterinary Pathology), by Application (Teleconsultation, Disease Diagnosis, Drug Discovery, Training & Education), by End User (Pharmaceutical & Biotechnology Companies, Hospital and Reference Laboratories, Academic & Research Institutes), Global Opportunity Analysis and Industry Forecast, 2020-2027

Report ID: HC0920DP | Published Date: Sept-2020 | Category: Healthcare Technology | Base Year: 2023 | Format: Report Formats

Global Digital Pathology Market Analysis:
Digital Pathology Market is expected to register a lucrative CAGR in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic 2018. The growth of this market is largely due to the rising use of digital pathology to enhance laboratory efficiency, increased prevalence of cancer, and the increasing use of digital pathology in drug discovery & related diagnostics. In the next few years, however, a lack of skilled pathologists will challenge the growth of the market.

Global Digital Pathology Market (2020-2027)

Market Definition:
Digital pathology is a unique platform that allows different pathology tools to become a single system including a single system that involves hematology, microbiology, clinical biochemistry, and immunology. Digital pathological research is used for the viewing, production, management, sharing, analysis, and interpretation of digital images of glass slides. DPS is intended to balance stream speed, network bandwidth usage efficiency, and image quality. In research and education, automated pathology systems were used. Digital pathology systems have been used in research education and applications.

Global Digital Pathology Market Segmentation:
By Product
• Scanners
• Software
• Communication Systems
• Storage Systems

By Type
• Human Pathology
• Veterinary Pathology

By Application
• Teleconsultation
• Disease Diagnosis
• Drug Discovery
• Training & Education

By End User
• Pharmaceutical & Biotechnology Companies
• Hospital and Reference Laboratories
• Academic & Research Institutes

By Geography
• North America
o U.S.
o Canada

• Western Europe
o Germany
o Italy
o U.K.
o France
o Spain
o Netherlands
o Belgium
o Switzerland
o Rest of Western Europe

• Eastern Europe
o Russia
o Poland
o Turkey
o Rest of Eastern Europe

• Asia-Pacific
o Japan
o China
o India
o South Korea
o Australia
o Rest of Asia-Pacific

• Latin America
o Mexico
o Brazil
o Argentina
o Rest of Latin America

• Middle East and Africa
o GCC Countries
o South Africa
o North Africa
o Egypt
o Rest of Middle East and Africa

• Recent Developments
• In 2019, Leica Biosystems (US) launched the Aperio GT 450 which helps the company to generate revenue.
• In 2019, F. uPath enterprise software was launched by Hoffmann-La Roche Ltd (Switzerland)

• Competitive Analysis:
The Digital Pathology Market is highly consolidated and the key players focus on several strategies such as new product launches, expansions, agreements, joint ventures, partnerships, and acquisitions, among others to increase their global presence. The report includes the market share of the Digital Pathology Market for Global, Western Europe, Asia-Pacific, North America, Latin America, Eastern Europe, and Middle East & Africa regions.

Key Market Players:
Major Key players operating in the Digital Pathology Market are 3DHISTECH Ltd., Danaher Corporation (Leica Microsystem), Glencoe Software, Inc., Hamamatsu Photonics K.K., Indica Labs Inc., Koninklijke Philips N.V., Nikon Corporation, PerkinElmer Inc., Roche (Ventana Medical Systems, Inc.), and Visiopharm A/S among others.

Research Methodology: Global Digital Pathology Market
Data collection modules with large sample sizes are used for data collection and base year analysis. Market share analysis and key trend analysis are the major factors for success in any market report. Market statistical and coherent models are used to analyze the market data. Please request an analyst call for more information on the research methodology

PheonixResearch’s consultants use their proprietary research methodology to evaluate data which involves data mining, analysis of the impact of data variables on the market, and primary validation. Furthermore, other data models consist of a market overview and guide, company positioning grid, vendor positioning grid, market timeline analysis, company market share analysis, standards of measurement, top to bottom analysis, and vendor share analysis.

Report Insights:
• To gain insights into the competitive milieu in the market
• End-user assessment /Customer behaviors
• Detailed Demand and Supply Assessment
• Key market drivers and restraints Analysis
• Competitive landscape of the key players involved
• In-depth analysis of the market segmentation

1. Introduction
1.1. Objectives Of The Study
1.2. Market Scope
1.2.1. Market Covered
1.2.2. Years Considered For The Study
1.3. Market Definition
1.4. Currency
1.5. Limitations
1.6. Stakeholders

2. Research Methodology
2.1. Research Design
2.1.1. Research Methodology Snapshot
2.1.2. Secondary Data
2.1.3. Key Data From Secondary Sources
2.1.4. Primary Data
2.1.5. Key Data From Primary Sources
2.2. Market Size Estimation
2.3. Market Breakdown And Data Triangulationmarket
2.4. Market Share Estimation
2.5. Assumptions For The Study

3. Executive Summary

4. Epidemiology

5. Industry Insights
5.1. Value Chain
5.2. Regulatory Landscape
5.2.1. North America
5.2.2. Europe
5.2.3. Asia
5.2.4. Row
5.3. Key Pipeline Products
5.4. Public-private Initiatives
5.5. Funding

6. Market Dynamics
6.1. Introduction
6.2. Market Dynamics
6.2.1. Drivers
6.2.2. Restraints
6.2.3. Opportunities
6.2.4. Challenges

7. Global Digital Pathology Market, By Product
7.1. Introduction
7.2. Scanners
7.3. Software
7.4. Communication Systems
7.5. Storage Systems

8. Global Digital Pathology Market, By Type
8.1. Introduction
8.2. Human Pathology
8.3. Veterinary Pathology

9. Global Digital Pathology Market, By Application
9.1. Introduction
9.2. Teleconsultation
9.3. Disease Diagnosis
9.4. Drug Discovery
9.5. Training & Education

10. Global Digital Pathology Market, By End User
10.1. Introduction
10.2. Pharmaceutical & Biotechnology Companies
10.3. Hospital And Reference Laboratories
10.4. Academic & Research Institutes

11. Global Digital Pathology Market, By Region
11.1. Introduction
11.2. North America
11.2.1. U.s.
11.2.2. Canada

11.3. Europe
11.3.1. Germany
11.3.2. France
11.3.3. U.k
11.3.4. Italy
11.3.5. Switzerland
11.3.6. Spain
11.3.7. Denmark
11.3.8. Netherlands
11.3.9. Belgium
11.3.10. Russia
11.3.11. Turkey
11.3.12. Norway
11.3.13. Rest Of Europe

11.4. Asia-pacific
11.4.1. Japan
11.4.2. India
11.4.3. China
11.4.4. South Korea
11.4.5. Australia
11.4.6. Thailand
11.4.7. Malaysia
11.4.8. Philippines
11.4.9. Singapore
11.4.10. Rest Of Asia-pacific

11.5. Latin America
11.5.1. Mexico
11.5.2. Brazil
11.5.3. Argentina
11.5.4. Peru
11.5.5. Columbia
11.5.6. Rest Of Latin America

11.6. Middle East And Africa
11.6.1. Uae
11.6.2. South Africa
11.6.3. Saudi Arabia
11.6.4. Egypt
11.6.5. Rest Of Middle East And Africa

12. Competitive Landscape
12.1. Competitive Landscape And Trends.
12.2. Agreements, Partnerships, And Collaborations
12.3. Product Launches And Approvals
12.4. Acquisitions
12.5. Expansions

13. Company Profile
13.1. 3dhistech Ltd.,
13.1.1. Overview
13.1.2. Revenue Analysis
13.1.3. Product Portfolio
13.1.4. Recent Development

13.2. Danaher Corporation (Leica Microsystem)
13.2.1. Overview
13.2.2. Revenue Analysis
13.2.3. Product Portfolio
13.2.4. Recent Development

13.3. Glencoe Software, Inc.
13.3.1. Overview
13.3.2. Revenue Analysis
13.3.3. Product Portfolio
13.3.4. Recent Development

13.4. Hamamatsu Photonics K.k
13.4.1. Overview
13.4.2. Revenue Analysis
13.4.3. Product Portfolio
13.4.4. Recent Development

13.5. Indica Labs Inc
13.5.1. Overview
13.5.2. Revenue Analysis
13.5.3. Product Portfolio
13.5.4. Recent Development

13.6. Koninklijke Philips N.v
13.6.1. Overview
13.6.2. Revenue Analysis
13.6.3. Product Portfolio
13.6.4. Recent Development

13.7. Nikon Corporation
13.7.1. Overview
13.7.2. Revenue Analysis
13.7.3. Product Portfolio
13.7.4. Recent Development

13.8. Perkinelmer Inc
13.8.1. Overview
13.8.2. Revenue Analysis
13.8.3. Product Portfolio
13.8.4. Recent Development

13.9. Roche (Ventana Medical Systems, Inc.)
13.9.1. Overview
13.9.2. Revenue Analysis
13.9.3. Product Portfolio
13.9.4. Recent Development

13.10. Visiopharm A/s
13.10.1. Overview
13.10.2. Revenue Analysis
13.10.3. Product Portfolio
13.10.4. Recent Development

14. Swot Analysis

15. Conclusion

16. About Us

17. Related Reports

      Licence Options